Otros artículos de Doris Hexsel
1. Hexsel D, Soirefmann M, Porto MD, Schilling-Souza J, Siega C. FIELDS OF ANHIDROTIC EFFECTS OF ABOBOTULINUMTOXINA IN PATIENTS WITH COMPENSATORY HYPERHIDROSIS. Dermatol Surg 2015;41 Suppl 1:S93-100.
2. Hexsel D, Soirefmann M, Porto MD, Siega C, Schilling-Souza J, Rodrigies TC. FIELDS OF MUSCULAR AND ANHIDROTIC EFFECTS OF 2 BOTULINUM TOXIN-A COMMERCIAL PREPARATIONS: A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, MULTICENTER STUDY. Dermatol Surg 2015;41 Suppl 1:S110-8.
3. Hexsel D, Hexsel C, Porto MD, Siega C. TRIPLE COMBINATION AS ADJUVANT TO CRYOTHERAPY IN THE TREATMENT OF SOLAR LENTIGINES: INVESTIGATOR-BLINDED, RANDOMIZED CLINICAL TRIAL. J Eur Acad Dermatol Venereol 2015;29(1):128-33.
4. Hexsel D, Soirefmann M, Porto MD, Schilling-Souza J, Siega C, Dal’forno T. SUPERFICIAL DERMABRASION VERSUS TOPICAL TRETINOIN ON EARLY STRIAE DISTENSAE: A RANDOMIZED, PILOT STUDY. Dermatol Surg 2014;40(5):537-44.
5. Hexsel D, Lacerda DA, Cavalcante AS, Machado Filho CA, Kalil CL, Ayres EL, Azulay-Abulafia L, Weber MB, Serra MS, Lopes NF, Cestari TF. EPIDEMIOLOGY OF MELASMA IN BRAZILIAN PATIENTS: A MULTICENTER STUDY. Int J Dermatol 2014;53(4):440-4.
6. Hexsel D, Brum C, Porto MD, Soirefmann M, Siega C, Schilling-Souza J, Rodrigues TC. FULL-FACE INJECTIONS OF VARIABLE TOTAL DOSES OF ABOBOTULINUM TOXIN TYPE A: A RANDOMIZED, PHASE IV CLINICAL TRIAL OF SAFETY AND EFFICACY. J Drugs Dermatol 2013;12(12):1356-62.
7. Hexsel D, Siega C, Schilling-Souza J, Porto MD, Rodrigues TC. A COMPARATIVE STUDY OF THE ANATOMY OF ADIPOSE TISSUE IN AREAS WITH AND WITHOUT RAISED LESIONS OF CELLULITE USING MAGNETIC RESONANCE IMAGING. Dermatol Surg 2013;39(12):1877-86.
8. Hexsel D, Hexsel C, Siega C, Schilling-Souza J, Rotta FT, Rodrigues TC. FIELDS OF EFFECTS OF 2 COMMERCIAL PREPARATIONS OF BOTULINUM TOXIN TYPE A AT EQUAL LABELED UNIT DOSES: A DOUBLE-BLIND RANDOMIZED TRIAL. JAMA Dermatol 2013;149(12):1386-91.
9. Hexsel D, Brum C, Siega C, Schilling-Souza J, Forno TD, Heckmann M, Rodrigues TC. EVALUATION OF SELF-ESTEEM AND DEPRESSION SYMPTOMS IN DEPRESSED AND NONDEPRESSED SUBJECTS TREATED WITH ONABOTULINUMTOXIN A FOR GLABELLAR LINES. Dermatol Surg 2013;39(7):1088–96.
10. Hexsel D, Brum C, do Prado DZ, Soirefmann M, Rotta FT, Dal'forno T, Rodrigues TC. FIELD EFFECT OF TWO COMMERCIAL PREPARATIONS OF BOTULINUM TOXIN TYPE A: A PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL. J Am Acad Dermatol 2012;67(2):226-32.
11. Hexsel D, Hexsel CL, Dal’Forno TO. A VALIDATED PHOTONUMERIC CELLULITE SEVERITY SCALE. J Eur Acad Dermatol Venereol 2009, 23, pp. 523-28.
12. Hexsel DM, Abreu M, Rodrigues TC, Soirefmann M, DO Prado DZ, Gamboa MM. SIDE-BY-SIDE COMPARISON OF AREAS WITH AND WITHOUT CELLULITE DEPRESSIONS USING MAGNETIC RESONANCE IMAGING. Dermatol Surg 2009;35(10):1471-77.
13. Hexsel DM, Mazzuco R. SUBCISION: A TREATMENT FOR CELLULITE. Int J Dermatol 2000;39(7):539-44.
Para comunicarse con Doris Hexsel mencionar a SIIC como
referencia:
doris@hexsel.com.br
Autor invitado
11 de mayo, 2015
Descripción aprobada
21 de mayo, 2015
Reedición siicsalud
6 de septiembre, 2023